Barclays PLC raised its stake in HCA Healthcare, Inc. (NYSE:HCA – Free Report) by 5.8% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 1,322,211 shares of the company’s stock after acquiring an additional 72,219 shares during the quarter. Barclays PLC’s holdings in HCA Healthcare were worth $617,287,000 at the end of the most recent reporting period.
A number of other large investors also recently bought and sold shares of HCA. Norges Bank acquired a new position in HCA Healthcare in the fourth quarter valued at approximately $1,262,513,000. Life Cycle Investment Partners Ltd purchased a new stake in shares of HCA Healthcare in the fourth quarter valued at approximately $374,037,000. Viking Global Investors LP increased its position in shares of HCA Healthcare by 58.5% in the second quarter. Viking Global Investors LP now owns 1,872,133 shares of the company’s stock valued at $717,214,000 after buying an additional 690,773 shares in the last quarter. Northwestern Mutual Wealth Management Co. increased its position in shares of HCA Healthcare by 4,545.5% in the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 663,337 shares of the company’s stock valued at $309,686,000 after buying an additional 649,058 shares in the last quarter. Finally, Danske Bank A S purchased a new stake in shares of HCA Healthcare in the third quarter valued at approximately $115,530,000. 62.73% of the stock is owned by institutional investors and hedge funds.
Analyst Ratings Changes
A number of analysts have recently commented on HCA shares. Barclays cut their price objective on HCA Healthcare from $551.00 to $496.00 and set an “overweight” rating for the company in a research report on Monday, April 27th. Leerink Partners cut their price objective on HCA Healthcare from $573.00 to $500.00 and set an “outperform” rating for the company in a research report on Monday, April 27th. Robert W. Baird dropped their price target on HCA Healthcare from $450.00 to $442.00 and set a “neutral” rating for the company in a research report on Wednesday, April 15th. Deutsche Bank Aktiengesellschaft dropped their price target on HCA Healthcare from $558.00 to $540.00 and set a “buy” rating for the company in a research report on Tuesday, April 28th. Finally, Jefferies Financial Group reiterated a “buy” rating and set a $525.00 price target on shares of HCA Healthcare in a research report on Friday, April 24th. Fifteen analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, HCA Healthcare currently has an average rating of “Moderate Buy” and a consensus target price of $506.14.
HCA Healthcare Stock Up 2.3%
Shares of NYSE:HCA opened at $387.25 on Friday. The business has a fifty day moving average of $429.60 and a two-hundred day moving average of $473.48. The stock has a market cap of $85.91 billion, a P/E ratio of 13.32, a PEG ratio of 1.23 and a beta of 1.12. HCA Healthcare, Inc. has a 52-week low of $330.00 and a 52-week high of $556.52.
HCA Healthcare (NYSE:HCA – Get Free Report) last issued its earnings results on Friday, April 24th. The company reported $7.15 earnings per share (EPS) for the quarter, missing the consensus estimate of $7.19 by ($0.04). The company had revenue of $19.11 billion during the quarter, compared to analysts’ expectations of $19.09 billion. HCA Healthcare had a net margin of 8.89% and a negative return on equity of 295.93%. The firm’s quarterly revenue was up 4.3% compared to the same quarter last year. During the same quarter in the previous year, the company earned $6.45 earnings per share. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. On average, equities analysts anticipate that HCA Healthcare, Inc. will post 30.07 earnings per share for the current year.
HCA Healthcare Dividend Announcement
The business also recently announced a quarterly dividend, which will be paid on Tuesday, June 30th. Shareholders of record on Tuesday, June 16th will be issued a $0.78 dividend. This represents a $3.12 annualized dividend and a yield of 0.8%. The ex-dividend date is Tuesday, June 16th. HCA Healthcare’s dividend payout ratio is presently 10.73%.
HCA Healthcare Profile
HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.
The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.
Featured Articles
- Five stocks we like better than HCA Healthcare
- Time to Sell? 3 Winners With Fading Technical Momentum
- Why These 2 Hotel Stocks Are Beating Travel Peers
- This Energy Stock Has Quietly Soared 130% in a Year
- 3 ‘Boring’ Dividend Stocks With Tasty Technical Setups
Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA – Free Report).
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
